This is a StreetInsider.com Premium Only Page

Ampio Pharma (AMPE) – Company Press Releases

Apr 3, 2024 02:33 PM Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation

Mar 25, 2024 05:00 PM Ampio Announces Voluntary Delisting and SEC Deregistration

Feb 14, 2024 05:45 PM Ampio Provides Update on Results from Pre-IND Enabling Studies

Jan 11, 2024 04:15 PM Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions

Nov 1, 2023 07:00 AM Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now

Oct 31, 2023 09:00 AM Ampio Pharmaceuticals to Present at the Emerging Growth Conference

Oct 5, 2023 04:30 PM Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201

Oct 4, 2023 07:00 AM Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now

Sep 26, 2023 09:15 AM Ampio Pharmaceuticals to Present at the Emerging Growth Conference

Aug 31, 2023 06:30 AM Ampio Pharmaceuticals Announces Reverse Stock Split

May 26, 2023 04:40 PM Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock

Apr 18, 2023 06:30 AM AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

Jan 17, 2023 08:20 AM AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

Dec 27, 2022 05:44 PM Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing Standards

Nov 17, 2022 04:53 PM Ampio Pharmaceuticals Announces NYSE American Removal of Trading Suspension

Nov 8, 2022 04:30 PM Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock Split

Oct 14, 2022 04:01 PM Ampio Pharmaceuticals Issues Letter to Stockholders

Oct 4, 2022 08:55 AM Ampio Pharmaceuticals Issues Letter to Stockholders

Oct 4, 2022 08:50 AM Ampio Pharmaceuticals Announces NYSE American Has Commenced Delisting Proceedings

Aug 3, 2022 08:30 AM Ampio Pharmaceuticals Issues Letter to Stockholders

Jun 2, 2022 04:30 PM Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

May 16, 2022 04:10 PM Ampio Pharmaceuticals Reports First-Quarter Financial Results

May 16, 2022 04:05 PM Ampio Independent Committee to Conduct Investigation

Apr 27, 2022 04:45 PM Ampio Pharmaceuticals, Inc. to Hold Conference Call

Apr 20, 2022 05:49 PM AMPIO PROVIDES REGULATORY UPDATE

Mar 29, 2022 04:10 PM Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights

Mar 23, 2022 08:30 AM Ampio Pharmaceuticals, Inc. to Hold Fourth Quarter 2021 Earnings and Business Update Call

Mar 9, 2022 08:30 AM Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference

Mar 2, 2022 04:05 PM Ampio Pharmaceuticals, Inc. Releases Positive Phase 3 Data Analysis for Ampion™ Targeting Severe Osteoarthritis of the Knee (OAK)

Mar 2, 2022 08:00 AM Ampio Pharmaceuticals, Inc. to Host a Conference Call and Webinar

Feb 10, 2022 09:00 AM Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes

Jan 6, 2022 08:30 AM Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference

Dec 16, 2021 08:35 AM Ampio Pharmaceuticals' CEO Mike Martino Issues Letter to Stockholders

Dec 13, 2021 08:30 AM AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING

Nov 29, 2021 04:01 PM Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1

Nov 23, 2021 05:30 PM Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino

Nov 22, 2021 09:15 AM Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave

Nov 10, 2021 04:01 PM Ampio Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides Business Update

Oct 28, 2021 09:15 AM Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Business Update

Oct 13, 2021 09:15 AM Ampio Pharmaceuticals Strengthens Management Team and Board of Directors

Sep 21, 2021 09:15 AM Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India

Sep 15, 2021 09:15 AM Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)

Aug 13, 2021 09:15 AM Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action

Aug 12, 2021 09:15 AM Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting

Aug 11, 2021 09:15 AM Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences

Aug 4, 2021 04:01 PM Ampio Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results and Provides Corporate Update

Jul 29, 2021 09:15 AM Ampio Pharmaceuticals to Present at the American College of Toxicology 42nd Annual Meeting

Jul 28, 2021 09:15 AM Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (COR

Jul 27, 2021 09:15 AM Ampio Pharmaceuticals to Present at Aspen Lung Conference

Jul 14, 2021 09:15 AM Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update